
Keywords: Mast cell; mastocytosis; well differentiated; KIT; imatinib; ASM; Aggressive systemic mastocytosis; BM; Bone marrow; CM; Cutaneous mastocytosis; CPA; Carboxypeptidase A; DCM; Diffuse cutaneous mastocytosis; FACS; Fluorescence-activated cell sorting; FSC;